Detalhe da pesquisa
1.
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
Br J Cancer
; 130(3): 442-449, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38102227
2.
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study.
Int J Cancer
; 153(7): 1376-1385, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403609
3.
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.
BMC Cancer
; 23(1): 966, 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37828434
4.
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study.
Gastric Cancer
; 26(3): 425-437, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881202
5.
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
Br J Cancer
; 126(9): 1264-1270, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34992255
6.
CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II-III colorectal carcinoma.
Mod Pathol
; 35(12): 2002-2010, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36202996
7.
An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes.
Mod Pathol
; 35(3): 427-437, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34545179
8.
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors.
Neuroendocrinology
; 112(6): 537-546, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348346
9.
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.
World J Surg Oncol
; 20(1): 131, 2022 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461290
10.
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
Int J Mol Sci
; 23(8)2022 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35457245
11.
Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort.
Future Oncol
; 17(25): 3343-3353, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011165
12.
Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics.
Clin Infect Dis
; 71(11): 2962-2964, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32392332
13.
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.
Br J Cancer
; 123(4): 518-524, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507854
14.
Genetic, structural, and functional characterization of POLE polymerase proofreading variants allows cancer risk prediction.
Genet Med
; 22(9): 1533-1541, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424176
15.
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE).
Ann Surg
; 270(1): 165-171, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29557879
16.
Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients.
Oncologist
; 24(12): e1331-e1340, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152084
17.
[Adapting the care pathway]. / Adapter le parcours de soins.
Soins Gerontol
; 24(135): 15-18, 2019.
Artigo
em Francês
| MEDLINE | ID: mdl-30765080
18.
Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.
Br J Cancer
; 119(3): 387, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29899390
19.
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors.
Oncologist
; 23(7): 766-e90, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242283
20.
Diversity of genetic events associated with MLH1 promoter methylation in Lynch syndrome families with heritable constitutional epimutation.
Genet Med
; 20(12): 1589-1599, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29790873